Research Tissue Bank for MedImmune

• Research type

  Research Tissue Bank

• IRAS ID

  200025

• Research summary

  MedImmune Research Tissue Bank

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  16/EE/0334

• Date of REC Opinion

  28 Sep 2016

• REC opinion

  Favourable Opinion

• Data collection arrangements

  All human biological samples and relevant data will be stored within one of three physical Medimmune Cambridge Tissue Banks;
  Medimmune Cambridge Pathology Human Tissue Bank (solid tissue samples e.g. FFPE blocks) & Database
  Medimmune Cambridge RMS HTA Human Tissue Bank (non-solid tissue e.g. PBMC) and RMS Database
  Medimmune Translational Sciences Sample Bank and Database (Plasma and Serum)

  Prior to receipt of any samples, Medimmune will request from the provider evidence of the informed consent (review of a consent template) and any relevant ethical approval statement covering this collection at the providers source, and will be review and approved, if compliant with the AstraZeneca HBS Standard and policies. The actual consent forms relevant to any sample will be held by the provider of the tissue to Medimmune.

• Research programme

  The research aim is to use samples stored in the MedImmune Biobank to aid the discovery and development of new drugs to benefit patients across the entire MedImmune disease portfolio including but not limited to Oncology, Respiratory, Inflammatory, Autoimmunity, Neurology, Cardiovascular and Metabolic diseases by Medimmune, AstraZeneca scientists or collaborating Scientists where there is a legal contract (Material Transfer Agreement) in place defining the research project to be undertaken

• Storage license

  12283

• RTBTitle

  MedImmune Research Tissue Bank

• Establishment organisation

  MedImmune

• Establishment organisation address

  Milstein Building

  Granta Park

  Cambridge

  CB21 6GH